Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 230
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02952547 | Safety and Pharmacokinetics Study of DWC20155 and DWC20156 in Healthy Subjects | ||
| NCT04613895 | Treatment Effect According to Timing of Administration of DWP14012 40 mg | ||
| NCT04632862 | The Efficacy and Safety of DWP16001 Compared to Placebo in the Treatment of Type 2 Diabetes Mellitus. | ||
| NCT05411887 | Study to Evaluate the Effect of Improving Systolic BP and LDL-C Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar Tab | ||
| NCT04535856 | Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients | ||
| NCT05184179 | Observational Study to Evaluate the Therapeutic Effectiveness and Safety of Olomax Tab | ||
| NCT02232360 | Effects of Combined Therapy With Statin Plus Fenofibrate on Coronary Atherosclerotic Plaque Compared With Statin Alone | ||
| NCT03736369 | Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 3) | ||
| NCT04064073 | Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With Metformin in Healthy Male Adults (Phase 1 Study) | ||
| NCT06141980 | Study to Evaluate the Long Term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes Mellitus | ||
| NCT06212960 | Evaluate the Safety and Explore the Efficacy of DWP712 With Moderate to Severe Glabellar Lines | ||
| NCT01634308 | Efficacy and Safety of Bongros-BMP Compared to Bio-oss for Regeneration of Alveolar Bone Tissue After Maxillary Sinus Floor Augmentation | ||
| NCT03574415 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Japanese, Caucasian and Korean | ||
| NCT06062030 | Efficacy and Safety of DWJ1609 for Bowel Cleansing Before Colonoscopy; | ||
| NCT04721535 | A Study of DWJ1248 in Prevention of COVID-19 Infection After the Exposure of SARS-COV-2 | ||
| NCT07371104 | Bioequivalence Study of DWZ2501 in Patients With Advanced BRCA-mutated High-grade Ovarian Cancer | ||
| NCT05321732 | The Drug Interaction of DWP16001 and DWC202010 After Oral Administration in Healthy Adults | ||
| NCT04490434 | Drug-drug Interaction Between DWP14012 and Three Different Kinds of NSAIDs | ||
| NCT06606093 | Evaluate the Efficacy and Safety of DWP16001 in Type 2 Diabetic Nephropathy with Moderate Renal Impairment Patients | ||
| NCT01094847 | Clinical Trials to Compare Mosapride Bioavailability Between DWJ1252 and Mosapride Medicine | ||
| NCT06437951 | to Evaluate the Safety/Tolerability and Pharmacokinetics, and Pharmacodynamics of DWP14012 Injection | ||
| NCT05816681 | Assessment of Elemental Impurities Level After Multiple Administration of DWJ1230 or DWB2001 in Subjects With Functional Diarrhea or Irritable Bowel Syndrome With Predominant Diarrhea. | ||
| NCT07256600 | PK and Safety Comparison of DWJ445 and DWC202506 in Healthy Volunteers | ||
| NCT04294251 | Efficacy and Safety of DWP450 in Subjects With Benign Masseteric Hypertrophy | ||
| NCT06354127 | DWP450 for Treating Moderate to Severe Glabellar Lines | ||
| NCT04782505 | Safety and Pharmacokinetics Evaluation Study According to the Dose of Camostat Mesylate in Healthy Volunteers | ||
| NCT04343547 | Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With DWC202001 and DWC202002 in Healthy Male Adults | ||
| NCT02665832 | Study of DWJ1351 in Healthy Male Volunteers | ||
| NCT02044250 | Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM) | ||
| NCT05410535 | To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomy | ||
| NCT03364985 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP16001 After Oral Administration in Healthy Male Volunteers | ||
| NCT03369990 | DWP450 Treatment in Subjects With Benign Masseteric Hypertrophy | ||
| NCT02946450 | Observational Study to Assess the Safety of Omnipure® Inj.(Iohexol) Contrast Media in CT Scanning Patients | ||
| NCT05660135 | Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia | ||
| NCT05414591 | Pharmacokinetics and Safety Following Administration of DWP16001 | ||
| NCT05813561 | The Efficacy and Safety of DWP14012 in Chinese Patients With Reflux Esophagitis | ||
| NCT04003441 | Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers | ||
| NCT03439020 | The Efficacy of Plastic Stent Anchoring to Reduce Migration of Metal Stent | ||
| NCT03184324 | Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 2, Therapeutic Exploratory Study) | ||
| NCT02947620 | Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3) | ||
| NCT05465668 | Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics of DWP16001 Drug A and C | ||
| NCT06427083 | Registry Study to Determine the Effectiveness and Safety of Weight Loss With Enavogliflozin in Patients With Type 2 Diabetes Mellitus | ||
| NCT04520022 | Safety and Effectiveness Study of Allogeneic Umbilical Cord Blood-derived Mesenchymal Stem Cell in Patients With RDEB | ||
| NCT06508645 | Study to Evaluate the Safety/Tolerability, PK and PD After Intravenous DWJ1521 Administration in Healthy Volunteers | ||
| NCT05607589 | The Safety, Tolerability, PK, and PD of DWP213388 After SAD and MAD Administration in Healthy Adult Subjects | ||
| NCT05832697 | An Exploratory Clinical Trial to Evaluate and Compare Safety and Pharmacokinetic Characteristics After Administration of the DWJ1439, DWJ1464, DWC202108 or DWC202109 in Healthy Adult Volunteers | ||
| NCT07479056 | Fexuprazan for Prevention of Upper Gastrointestinal Bleeding in High Bleeding Risk Patients Receiving Dual Antiplatelet Therapy | ||
| NCT03016494 | Safety and Pharmacokinetics Study of Fixed Dose Combination of DWJ1386 Compared With Co-administration of DWC20155 and DWC20156 in Healthy Subjects | ||
| NCT06751121 | Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori | ||
| NCT01634321 | The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty |
